Mark J. Murray
Director/Board Member at Genevant Sciences Corp.
Mark J. Murray active positions
| Companies | Position | Start | End |
|---|---|---|---|
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Director/Board Member | - | - |
Career history of Mark J. Murray
Former positions of Mark J. Murray
| Companies | Position | Start | End |
|---|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Director/Board Member | 2011-10-13 | 2019-06-23 |
| Chief Executive Officer | 2008-05-29 | 2019-06-23 | |
| President | 2008-05-29 | 2019-06-23 | |
Protiva Biotherapeutics, Inc.
 Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Chief Executive Officer | 2000-08-31 | 2008-12-01 |
| Founder | 2008-12-01 | 2008-12-01 | |
| President | - | 2008-12-01 |
Training of Mark J. Murray
| Oregon Health & Science University | Doctorate Degree |
Statistics
International
| United States | 3 |
| Canada | 3 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| President | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Health Technology |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Health Technology |
- Stock Market
- Insiders
- Mark J. Murray
- Experience
